Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multi Vessel Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07541391
What this trial is testing

Autologous Chimeric Antigen Receptor (CAR) T-cells Targeting the Kappa Myeloma Antigen (KMA) in Kappa Restricted Multiple Myeloma Patients With Relapsed/Refractory Disease

Who this might be right for
Relapsed/Refractory Multiple Myeloma
Peter MacCallum Cancer Centre, Australia 12
Not applicableStudy completedNCT05951985
What this trial is testing

High Intensity Functional Training for Individuals With Neurologic Diagnoses and Their Care Partners

Who this might be right for
Neurologic DisorderParkinson DiseaseSpinal Cord Injuries+5 more
Arkansas Colleges of Health Education 100
Not applicableStudy completedNCT03174535
What this trial is testing

Risk Assessment Model for Ischemic Stroke Endpoint Events

Who this might be right for
Ischemic Stroke
China Academy of Chinese Medical Sciences 3,000
Large-scale testing (Phase 3)Active Not RecruitingNCT05552976
What this trial is testing

Evaluate Mezigdomide in Combination With Carfilzomib and Dexamethasone (MeziKD) Versus Carfilzomib and Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma (SUCCESSOR-2)

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Bristol-Myers Squibb 606
Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Large-scale testing (Phase 3)Study completedNCT00185276
What this trial is testing

Magnevist® Injection Enhanced MRA at Two Dose Levels Compared to Non Contrast MRA for the Detection of Structural Abnormalities of the Infrarenal Aorta and Peripheral Arteries

Who this might be right for
Peripheral Vascular Disease
Bayer 365
Not applicableEnded earlyNCT01077440
What this trial is testing

Presence of Donor-Derived DNA in Semen Samples From Cancer Survivors Who Underwent Donor Stem Cell Transplant

Who this might be right for
Cancer SurvivorChronic Myeloproliferative DisordersLeukemia+6 more
Vanderbilt University 24
Very early researchLooking for participantsNCT06045091
What this trial is testing

To Evaluate the Safety and Efficacy of Human BCMA Targeted CAR-NK Cells Injection for Subjects With R/R MM or PCL

Who this might be right for
Multiple MyelomaPlasma Cell Leukemia
Hrain Biotechnology Co., Ltd. 18
Early research (Phase 1)Study completedNCT05011097
What this trial is testing

A Phase I Clinical Trial of Y150 in the Treatment of Relapsed or Refractory Multiple Myeloma

Who this might be right for
Relapsed or Refractory Multiple Myeloma
Wuhan YZY Biopharma Co., Ltd. 20
Not applicableStudy completedNCT04992910
What this trial is testing

Multi-field Functional Electrical Stimulation for Distal Upper-limb Rehabilitation After Subacute Stroke: a Pilot Randomised Controlled Trial

Who this might be right for
StrokeUpper Extremity Paresis
Maimónides Biomedical Research Institute of Córdoba 16
Post-approval studies (Phase 4)Study completedNCT04137510
What this trial is testing

Bioflow-DAPT Study

Who this might be right for
Coronary Artery Disease
Biotronik AG 1,948
Testing effectiveness (Phase 2)Looking for participantsNCT06536413
What this trial is testing

ATRA and Carfilzomib in Plasma Cell Myeloma Patients

Who this might be right for
Multiple Myeloma
The Methodist Hospital Research Institute 42
Not applicableUnknownNCT02184897
What this trial is testing

Pharmacokinetic and Pharmacodynamic Study of Lenograstim for Hematopoietic Stem Cell Mobilization

Who this might be right for
Multiple Myeloma
Asan Medical Center 24
Large-scale testing (Phase 3)Study completedNCT00672997
What this trial is testing

A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension

Who this might be right for
Open-Angle GlaucomaOcular Hypertension
Alcon Research 301
Testing effectiveness (Phase 2)Ended earlyNCT06833190
What this trial is testing

REGN5381 in Adult Participants With Uncontrolled Hypertension

Who this might be right for
Uncontrolled Hypertension
Regeneron Pharmaceuticals 34
Testing effectiveness (Phase 2)Study completedNCT00051597
What this trial is testing

A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

Who this might be right for
Hodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more
Seagen Inc. 70
Not applicableEnded earlyNCT04718610
What this trial is testing

Heart Rate Variability, Vagus Nerve and Cancer

Who this might be right for
Lung CancerColorectal CancerMultiple Myeloma+1 more
Centre Hospitalier Henri Duffaut - Avignon 25
Large-scale testing (Phase 3)Ended earlyNCT00796510
What this trial is testing

Study Providing Monotherapy (Sitaxsentan) And Combination Therapy (Sitaxsentan+Sildenafil) To Subjects With Pulmonary Arterial Hypertension (PAH) To Assess Long-Term Safety

Who this might be right for
Pulmonary Arterial HypertensionPulmonary Hypertension
Pfizer 3
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Testing effectiveness (Phase 2)Study completedNCT00396331
What this trial is testing

AMD3100 (Plerixafor) With G-CSF in Poor Mobilizing Adult Patients Who Previously Failed Hematopoietic Stem Cell (HSC) Collection/Attempts

Who this might be right for
Autologous Stem Cell Transplantation
Genzyme, a Sanofi Company 100
Next Page